Her research focuses on Angelman syndrome, which she considers a puzzle. Angelman syndrome is a debilitating neurological developmental disorder with no therapy or cure, and the diagnosis is considered a tragedy by most. Dr. Chamberlain’s goal is to find a treatment therapy through her research using iPSC (induced Pluripotent Stem Cells) to model and study human imprinting disorders with chromosome 15 mutations like Angelman syndrome.